药品带量采购的阻力、压力与垄断力问题探讨

带量采购是深化三医联动改革的重要尝试，药品集采作为医保改革的抓手试图撬动医疗及医药领域改革，为持续推进医疗卫生制度改革走向深入带来一线曙光。带量采购政策本质上涉及不同利益的再分配，藉由政府宏观调控及微观规制手段，最终实现药价降低、群众普惠的效果。基于对带量采购的理论分析及目前试点过程中存在的阻力、压力与垄断力问题，提出平衡理念为带量采购助推三医联动改革走向深远提供了一种思路。

Discussion on the Resistance,Pressure and Monopoly Power of Mass Drug Procurement

Mass procurement is an important attempt to deepen the interactive system reforms of medical insurance, healthcare, pharmaceutical production and distribution. As the pioneer of medical insurance reform, the centralized procurement of drugs tries to leverage the medical and pharmaceutical reform, and brings a glimmer of light for the continuous advancement of the reform of medical and health system. The mass procurement policy essentially involves the redistribution of different benefits. Through government's macro-control and micro-regulatory measures, it will reduce drug prices and benefit the masses ultimately. Based on the theoretical analysis of quantity purchasing and the problems of resistance, pressure and monopoly power in the current pilot process, the author puts forward the balance concept to provide an idea for further interactive system reforms pushed by mass drug procurement.